[HTML][HTML] New insights into the non-enzymatic function of HDAC6

Y Zhu, M Feng, B Wang, Y Zheng, D Jiang… - Biomedicine & …, 2023 - Elsevier
Abstract Histone deacetylase 6 (HDAC6) is a class IIb histone deacetylase that contains two
catalytic domains and a zinc-finger ubiquitin binding domain (ZnF-UBP) domain. The …

Zinc-dependent deacetylases (HDACs) as potential targets for treating Alzheimer's disease

Y Li, S Lin, Z Gu, L Chen, B He - Bioorganic & Medicinal Chemistry Letters, 2022 - Elsevier
Alzheimer's disease (AD) as the most prevalent dementia type has become one of the
greatest threats to the health and life of the elder people worldwide. Although there has …

Histone deacetylase inhibitors VPA and WT161 ameliorate the pathological features and cognitive impairments of the APP/PS1 Alzheimer's disease mouse model by …

M Zhang, W Wang, Q Ye, Y Fu, X Li, K Yang… - Alzheimer's Research & …, 2024 - Springer
Background Alzheimer's disease (AD) is a degenerative neurological disorder. Recent
studies have indicated that histone deacetylases (HDACs) are among the most prominent …

[HTML][HTML] Histone deacetylase-6 modulates Tau function in Alzheimer's disease

T Qureshi, S Chinnathambi - … et Biophysica Acta (BBA)-Molecular Cell …, 2022 - Elsevier
Abstract Alzheimer's disease (AD), one of the major tauopathies, is multifactorial with a
massive demand for disease-modifying treatments rather than symptom management. An …

Chromatin ubiquitination Guides DNA double strand break signaling and repair

KG Kolobynina, A Rapp, MC Cardoso - Frontiers in Cell and …, 2022 - frontiersin.org
Chromatin is the context for all DNA-based molecular processes taking place in the cell
nucleus. The initial chromatin structure at the site of the DNA damage determines both …

HTRA1 promotes EMT through the HDAC6/Ac‐α‐tubulin pathway in human GBM cells

W Zhao, Y Wu, S Wang, F Zhao, W Liu… - CNS Neuroscience …, 2024 - Wiley Online Library
Background The infiltrative nature of human gliomas renders complete surgical removal of
tumors futile. Thus, illuminating mechanisms of their infiltrative properties may improve …

Role of histone deacetylase inhibitors in non-neoplastic diseases

C Zhou, D Zhao, C Wu, Z Wu, W Zhang, S Chen… - Heliyon, 2024 - cell.com
Background Epigenetic dysregulation has been implicated in the development and
progression of a variety of human diseases, but epigenetic changes are reversible, and …

Histone deacetylase 6 as a novel promising target to treat cardiovascular disease

YX Wu, BQ Li, XQ Yu, YL Liu, RH Chui, K Sun… - Cancer …, 2024 - Wiley Online Library
Abstract Histone deacetylase 6 (HDAC6) belongs to a class of epigenetic targets that have
been found to be a key protein in the association between tumors and cardiovascular …

[PDF][PDF] Histone deacetylase inhibitors VPA and WT161 ameliorate the pathological features and cognitive impairments of the Alzheimer's disease mouse model by …

M Zhang, W Wang, Q Ye, Y Fu, X Li, K Yang, F Gao… - 2023 - scholar.archive.org
Background Alzheimer's disease (AD) is a degenerative neurological disorder. Recent
studies have indicated that histone deacetylases (HDACs) are among the most prominent …

Selektive HDAC6-Inhibitoren und „Proteolysis Targeting Chimeras “(PROTACs): Synthese und biologische Testung

S Scheuerer - 2024 - epub.uni-regensburg.de
Die Inhibition von HDAC6 hat sich ua bei der Behandlung von neurodegenerativen
Erkrankungen, Autoimmunerkrankungen und Tumorerkrankungen als nützlich erwiesen …